About Nanoplex Technologies
Nanoplex Technologies is a company based in Mountain View (United States) founded in 2002 was acquired by Oxonica in December 2005. Nanoplex Technologies operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Mountain View, United States
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nanoplex Technologies
Detailed funding history for Nanoplex Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Nanoplex Technologies
Nanoplex Technologies has secured backing from 1 investor. Prominent investors backing the company include Oxonica.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Nano-materials are developed and supplied by Oxonica for industrial uses.
|
Locked | Locked | Locked |
Investor details for Nanoplex Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nanoplex Technologies
Investment portfolio details for Nanoplex Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nanoplex Technologies
Detailed financials for Nanoplex Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nanoplex Technologies Comparisons
Peer comparison for Nanoplex Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nanoplex Technologies
Nanoplex Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Nanoplex Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nanoplex Technologies
Complete news archive for Nanoplex Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanoplex Technologies
Nanoplex Technologies was founded in 2002.
Nanoplex Technologies is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Nanoplex Technologies was founded in 2002 in Mountain View, United States. Nanoparticle products are developed, manufactured, and marketed for medical diagnostics and brand security sectors. Focus is placed on nanomaterials synthesis, functionalization, bioassay development, optical engineering, and software creation. The flagship offering relies on surface-enhanced Raman scattering-active nanoparticles, detectable in trace amounts via portable near-infrared instrumentation.
Nanoplex Technologies's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Nanoplex Technologies has 1 investor. Key investors include Oxonica.